{"DataElement":{"publicId":"2688817","version":"1.1","preferredName":"Stage Prognostic Factor Collaborative Staging Metastasis Coding Code","preferredDefinition":"Records how the code for CS Mets at DX [2850] was determined based on the diagnostic methods employed.","longName":"2688815v1.0:2647615v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2688815","version":"1","preferredName":"Stage Prognostic Factor Collaborative Staging Metastasis Coding","preferredDefinition":"Belongs to the set of Collaborative Staging (CS) data items effective with 2004 diagnosis.","longName":"2688190v1.0:2688813v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2688190","version":"1","preferredName":"Stage Prognostic Factor","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"C16899:C18959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C0FC8A1-D62E-5124-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-09","modifiedBy":"ONEDATA","dateModified":"2007-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2688813","version":"1","preferredName":"Collaborative Staging Metastasis Coding","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).:Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.:The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis. (from Wikipedia)","longName":"C62575:C19151:C45971","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collaborative Staging","conceptCode":"C62575","definition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Coding","conceptCode":"C45971","definition":"The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3D5706-F5A1-1B0E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-11","modifiedBy":"ONEDATA","dateModified":"2007-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C3D5706-F5B2-1B0E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2647615","version":"1","preferredName":"Collaborative Staging Metastasis Coding Code","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits)._Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer._A system of numbered categories for representation of data.","longName":"2647615v1.0","context":"PS-CC","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435030","version":"1","preferredName":"NCI Administrative Concept","preferredDefinition":"Conceptual entities required by NCI operations and systems. Includes administrative, financial, organizational and quasi-scientific concepts required for NCI operations and systems. ","longName":"C28389","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432182-1611-25E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2647614","version":"1","preferredName":"Collaborative Staging Metastasis Coding Code","preferredDefinition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).:Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.:The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis. (from Wikipedia):A system of numbered categories for representation of data.","longName":"C62575:C19151:C45971:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collaborative Staging","conceptCode":"C62575","definition":"A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Coding","conceptCode":"C45971","definition":"The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3240F46C-52A8-4D1F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-06","modifiedBy":"ONEDATA","dateModified":"2007-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3240F46C-52B9-4D1F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-06","modifiedBy":"CURTIST","dateModified":"2011-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"5899845","version":"1","longName":"StageProgFactors16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464319","version":"1","longName":"StageProgFactors18","context":"PS-CC"}]}],"AlternateNames":[{"name":"CS METS EVAL","type":"NAACCR Item Name","context":"PS-CC"},{"name":"2860","type":"NAACCR Item #","context":"PS-CC"},{"name":"CS Metastatsis Evaluation","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"CS Metastasis Evaluation","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"CS Mets Eval","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Collaborative Staging Metasta","type":"Preferred Question Text","description":"Collaborative Staging Metastasis Evaluation","url":null,"context":"PS-CC"},{"name":"CS Mets Eval Description","type":"COMMENT","description":"\"CS Mets Eval\" records how the code for item \"CS Mets at DX\" [2850] was determined based on the diagnostic methods employed. This data item is used in CS to identify whether the M (of AJCC TNM) was clinically or pathologically diagnosed and by what methods, \"CS Mets Eval\" is used to derive the Derived AJCC M Descriptor [2990].","url":null,"context":"PS-CC"},{"name":"Collaborative Staging (CS) Reference Manuals","type":"REFERENCE","description":"The Collaborative Stage Data Collection System (CS) Web pages serve as the main repository for CS-related items including coding instructions, software, and education and training resources for cancer registrars and cancer registry software vendors.","url":"http://www.cancerstaging.org/cstage/manuals.html","context":"PS-CC"},{"name":"SEER Coding and Staging Manuals","type":"REFERENCE","description":"Coding and Staging Manuals for the Surivellance Epidemiology and End Results Program","url":"http://seer.cancer.gov/tools/codingmanuals/index.html","context":"PS-CC"},{"name":"AJCC Cancer Staging Manual","type":"REFERENCE","description":"See the AJCC Cancer Staging Manual, current edition, for site-specific categories for the TNM elements and stage groups.","url":null,"context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD8B1BBC-2C10-8F0E-E040-BB89AD4364FD","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-22","modifiedBy":"DWARZEL","dateModified":"2022-05-23","changeDescription":"09/22/2011 - tc - Updated definition as per V12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}